| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |